Episode 17: Norwest Venture Partners' Tiba Aynechi
BioVenture VoiCes with Chris Garabedian
00:00
Innovative Investments in Biotech: The Impact of ECG Technology
This chapter highlights the speaker's investment insights at Novo, specifically on iRhythm's innovative ECG patch that enhances heart rhythm monitoring. The discussion emphasizes the impact of this technology on patient care for arrhythmia and the speaker's fulfillment from contributing to a significant advancement in medical standards.
Play episode from 27:35
Transcript
